221 related articles for article (PubMed ID: 23288981)
1. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
4. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.
Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E
Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804
[TBL] [Abstract][Full Text] [Related]
5. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
6. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
7. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
Martínez-Rodríguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
Andlauer O; Moore H; Jouhier L; Drake C; Peppard PE; Han F; Hong SC; Poli F; Plazzi G; O'Hara R; Haffen E; Roth T; Young T; Mignot E
JAMA Neurol; 2013 Jul; 70(7):891-902. PubMed ID: 23649748
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
[TBL] [Abstract][Full Text] [Related]
11. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.
Han F; Lin L; Schormair B; Pizza F; Plazzi G; Ollila HM; Nevsimalova S; Jennum P; Knudsen S; Winkelmann J; Coquillard C; Babrzadeh F; Strom TM; Wang C; Mindrinos M; Fernandez Vina M; Mignot E
Sleep; 2014 Oct; 37(10):1601-8. PubMed ID: 25197808
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
13. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
[TBL] [Abstract][Full Text] [Related]
14. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.
Jeong JH; Hong SC; Shin YK; Han JH; Lee SP
J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265
[TBL] [Abstract][Full Text] [Related]
15. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
Drakatos P; Leschziner G
J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
[TBL] [Abstract][Full Text] [Related]
16. A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.
Dauvilliers Y; Maret S; Bassetti C; Carlander B; Billiard M; Touchon J; Tafti M
Neurology; 2004 Jun; 62(11):2137-8. PubMed ID: 15184641
[No Abstract] [Full Text] [Related]
17. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR
Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180
[TBL] [Abstract][Full Text] [Related]
18. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
19. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
Heier MS; Jansson TS; Gautvik KM
J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
